December 1, 2017 / 6:25 PM / a year ago

FDA panel recommends Zika testing of donated blood be relaxed

Dec 1 (Reuters) - Advisers to the U.S. Food and Drug Administration on Friday recommended that the requirements for screening blood donations for the Zika virus be relaxed due to diminished risk of transfusion-transmitted infection.

The advisory panel voted that instead of requiring Zika virus testing on each individual blood donation, tests could be conducted on "mini-pools" in which blood samples are pooled before testing.

In 2016 the FDA advised U.S. blood centers to screen all blood donations for Zika. (Reporting by Toni Clarke in Washington; Editing by Cynthia Osterman)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below